MRI Funding Targets Sickle Cell Brain Injuries in Kids

King’s College London

BMEIS researchers have received seed funding for a new project to advance MRI detection of Sickle Cell disease-related brain injury in children.

image of a brain scan

King's researchers have received seed funding from the Royal College of Radiologists to use advanced medical imaging technology to benefit children with sickle cell disease.

The project will utilise cutting-edge brain imaging available via the London Collaborative Ultra High Field 7T MRI scanner, based at the School of Biomedical Engineering & Imaging Sciences (BMEIS), to investigate advanced detection techniques for sickle cell disease related brain injury.

Our exciting interdisciplinary study, for the first time, brings advanced 7 Tesla brain MRI to children with sickle cell disease - a debilitating condition in great need of further research. This should allow much better detection of the tiny strokes and narrowed blood vessels, affecting these children, ultimately allowing earlier and more tailored treatments.

Dr Jon Cleary, Adjunct Senior Lecturer BMEIS & Consultant Neuroradiologist, GSTT.

The 7T scanner can create significantly more detailed images than a standard scan, including blood flow measurements of tiny arteries which would usually be invisible on hospital scanners.

Diseased red blood cells can block and inflame both large and small arteries in the brain, leading to tiny stokes which accumulate over time.

Very small strokes may not be visible on standard scans and damage to the developing brain can lead to significant thinking and movement difficulties by adulthood.

The project aims to create tools for improving earlier diagnosis of brain injury, guiding patient treatment, and to help test new sickle cell disease medications.

Scan
Exquisite detailed anatomy of the brain's arteries seen on a 7 Tesla MRI scan, showing the tiny lenticulostriate arteries (blue arrows) which may become blocked and cause the small strokes seen in sickle cell disease.

This exciting project will harness cutting-edge brain imaging in order to investigate early image biomarkers of brain injury in children with sickle cell disease. The project is truly interdisciplinary, bringing together scientific and clinical colleagues within BMEIS and at the Evelina Children's Hospital to address this important condition.

Professor Sebastien Ourselin, FREng FMedSci, Head of School of Biomedical Engineering & Imaging Sciences.

The research team is comprised of:

  • Dr Jon Cleary. Adjunct Senior Lecturer BMEIS & Consultant Neuroradiologist, GSTT
  • Dr. Philip Benjamin, Consultant Neuroradiologist, St. George's Hospital  
  • Dr. Samah Babiker, Consultant Paediatric Haematologist, Evelina Children's Hospital
  • Dr. Saras Sabanathan, Consultant Paediatric Neurologist, Evelina Children's Hospital  
  • Dr. Jonathan O'Muircheartaigh, IOPPN 
  • Prof. David Carmichael, BMEIS 

In this story

Jon Cleary

Adjunct Senior Lecturer BMEIS & Consultant Neuroradiologist, GSTT

Sebastien Ourselin

Professor of Healthcare Engineering

David  Carmichael

Professor in Magnetic Resonance Imaging

Jonathan O'Muircheartaigh

Reader in Developmental Neuroimaging

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.